Global Meningococcal Vaccines Market Size Is Booming Worldwide with Share, Top Key Players 2024-2032

Meningococcal Vaccines Market Size And Forecast

Meningococcal Vaccines Market size was valued at USD 4.40 Billion in 2020 and is projected to reach USD 11.12 Billion by 2028, growing at a CAGR of 12.39% from 2021 to 2028.

The factors driving the growth of the Global Meningococcal Vaccines Market are the rising incidence of meningitis across the world, and high government and private expenditure on research and development of the meningococcal vaccine are fuelling the growth of the market. The Global Meningococcal Vaccines Market report provides a holistic evaluation of the market. The report offers a comprehensive analysis of key segments, trends, drivers, restraints, competitive landscape, and factors that are playing a substantial role in the market.

Global Meningococcal Vaccines Market Definition

The meningococcal vaccine is used to treat contagious infections of the membranes that surround the brain and spinal cord caused by Neisseria meningitides. There are three types of vaccines present to act against meningococcal disease which target serogroups A, C, W-135, and Y of meningococcus. The meningococcal vaccines are primarily used to immunize children, preteens or teens, and adults against invasive diseases caused by Neisseria meningitides. The vaccine can be of different types such as quadrivalent vaccines, bivalent vaccines, serogroup A, serogroup B, and serogroup X. The quadrivalent vaccines have higher usage and it provides immunization against four different types of meningococcal bacteria such as A, C, Y, and W-135. The bivalent vaccines are available for Serogroups C and Y and other types of variants.

Viral and bacterial infections are the main causes of meningitis. There are other additional types of meningitis. Two further potential culprits are fungus and cancer. These, however, are not as typical as the others. For many strains of bacterial meningitis, there is a vaccination. One type of meningitis for which vaccines are available is meningococcal meningitis, which is brought on by Neisseria meningitides. Although bacterial meningitis is more severe if not identified and treated right away, viral meningitis is more frequent. Sanofi’s MenQuadfi, the most recent advancement in meningococcal (MenACWY) immunization, received FDA approval in 2020. In the United States, the vaccination is intended for use in people 2 years of age and older.

Global Meningococcal Vaccines Market Overview

The global meningococcal vaccine is driven by the rising incidence of meningitis across the world has been majorly fuelling the growth of the Global Meningococcal Vaccines Market. Meningitis has recently more prevalent in African nations. The most common variants are A, B, C, W, X, and Y types. With a rise in meningitis, the high demand for meningococcal vaccines is witnessed. This bacteria has circulated unpredictably in varying occurrences in different age groups across numerous geographic regions. In addition, high government and private expenditure on research and development of the meningococcal vaccine are fuelling the growth of the Global Meningococcal Vaccines Market.

To implement vaccinations that cover all strains currently in circulation and monitor their effects on disease burden reduction once they are introduced, improved surveillance is necessary. The global invasive bacterial vaccine-preventable disease (IB-VPD) surveillance network is made up of sentinel surveillance hospitals and laboratories that report clinical, epidemiological, and laboratory data on three types of syndromes in children aged 5 years to national ministries of health and WHO. By putting in place an efficient monitoring system for the detection and identification of public health issues, the incidence of the disease is greatly decreased.

Some of the factors restraining the growth of the Global Meningococcal Vaccines Market are maintenance of the cold chain for the delivery of vaccines leads to increase in the cost of vaccination it is a key restraining factor for the market growth. In addition, owing to the stringent government policies for the approval of new vaccines and at times recall of certain products owing to contamination are hampering the growth of the Global Meningococcal Vaccines Market. Further, the World Health Organization is promoting strategies for the prevention of meningitis and is hoping to introduce this vaccine in moderate or high-rate of disease countries in west and central region Africa, which is suffering from meningitis and they hope to achieve.

This would create growth opportunities in this market. Recently, during the covid-19 outbreak, the Global Meningococcal Vaccines Market has witnessed a downfall owing to an increase in manufacturing, research, and development of coronavirus vaccines and traveling restrictions the spread of meningitis was decreased owing to which the decrease in demand for the meningococcal vaccine was witnessed. Although the demand for meningococcal vaccines will increase in the forecasted period.

Global Meningococcal Vaccines Market: Segmentation Analysis

The Global Meningococcal Vaccines Market is Segmented on the basis of Product Type, End-User, And Geography.

Meningococcal Vaccines Market, By Product Type

• Quadrivalent Vaccines
• Bivalent Vaccines
• Serogroup A
• Serogroup B
• Serogroup X

Based on Product Type, The market is classified into Quadrivalent Vaccines, Bivalent Vaccines, Serogroup A, Serogroup B, and Serogroup X. The quadrivalent vaccines sub-segment has a larger market share and is anticipated to be the fastest-growing market owing to the higher use of quadrivalent vaccines. The quadrivalent vaccines have a higher usage rate owing to the reason that it provides immunization against four different types of meningococcal bacteria. These four types of bacteria are A, C, Y, and W-135. The vaccine can be of either conjugate or polysaccharide. Owing to these factors quadrivalent vaccines have a larger market share and are expected to have a larger market share in the forecasted period.

Meningococcal Vaccines Market, By End-User

• Children
• Pre-teens or Teens
• Adults

Based on End-User, The market is classified into Children, Pre-teens or Teens, and Adults. The pre-teens or teens sub-segment has a larger market share and is anticipated to be the fastest-growing market owing to an increase in meningitis cases and it was mainly observed in children. In addition, government initiatives and owing to an increase in meningococcal vaccine awareness and a rise in consumption of meningococcal vaccine are witnessed and on other hand a fall in meningitis cases. It is expected to have a larger market share in the forecasted period. The children sub-segment has the larger market share after the pre-teens or teens sub-segment.

Meningococcal Vaccines Market, By Geography

• North America
• Europe
• Asia Pacific
• Rest of the world

On the basis of Geography, The Global Meningococcal Vaccines Market is classified into North America, Europe, Asia Pacific, and the Rest of the world. The North American region has the largest market share and is anticipated to be the fastest-growing market owing to high infrastructural development, rising immunization programs by various organizations, and government initiatives are some of the factors contributing to the North American region to have largest market share and will increase in the forecasted period. The European region is the second-largest contributor to the Global Meningococcal Vaccines Market. In recent years, the Asia Pacific region has emerged as the largest growing market owing to a rapid increase in healthcare infrastructure development in the region.

Key Players

The “Global Meningococcal Vaccines Market” study report will provide valuable insight with an emphasis on the global market including some of the major players such as GlaxoSmithKline plc., Pfizer, Merck & Co., Serum Institute of India, Sanofi, Johnson & Johnson, AstraZeneca, Bavarian Nordic, BIO MED Private Limited, Chongqing Zhifei Biological Products Co., Bio-Manguinhos. The competitive landscape section also includes the above-mentioned players’ key development strategies, market share, and market ranking analysis.

Report Scope

Top Trending Reports:

Research Methodology of Market Research

To know more about the Research Methodology and other aspects of the research study, kindly get in touch with our .

Reasons to Purchase this Report

• Qualitative and quantitative analysis of the market based on segmentation involving both economic as well as non-economic factors• Provision of market value (USD Billion) data for each segment and sub-segment• Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market• Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region• Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions and acquisitions in the past five years of companies profiled• Extensive company profiles comprising of company overview, company insights, product benchmarking and SWOT analysis for the major market players• The current as well as future market outlook of the industry with respect to recent developments (which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions• Includes an in-depth analysis of the market of various perspectives through Porter’s five forces analysis• Provides insight into the market through Value Chain• Market dynamics scenario, along with growth opportunities of the market in the years to come• 6-month post sales analyst support

Customization of the Report

• In case of any please connect with our sales team, who will ensure that your requirements are met.